Gemcitabine/cisplatin versus 5-fluorouracil/mitomycin C chemoradiotherapy in locally advanced pancreatic cancer: a retrospective analysis of 93 patients

European cancer mortality predictions for the year 2011

(2011) M. Malvezzi et al.   ANNALS OF ONCOLOGY

Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: A meta-analysis

(2011) Chang-Peng Zhu et al.   RADIOTHERAPY AND ONCOLOGY

Pancreatic Cancer

(2010) Manuel Hidalgo   NEW ENGLAND JOURNAL OF MEDICINE

Long-Term Outcome of Mitomycin C- and 5-FU-Based Primary Radiochemotherapy for Esophageal Cancer

(2010) Maria Wolf et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Volumetric Modulated Arc Therapy for Advanced Pancreatic Cancer

(2010) Wietse Eppinga et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages

(2010) Sonja Gillen et al.   PLOS MEDICINE

Downstaging of Pancreatic Carcinoma after Neoadjuvant Chemoradiation

(2009) Dominik Tinkl et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer

(2008) Volker Heinemann et al.   BMC CANCER

Single-Nucleotide Polymorphisms of DNA Damage Response Genes Are Associated with Overall Survival in Patients with Pancreatic Cancer

(2008) T. Okazaki et al.   CLINICAL CANCER RESEARCH